These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16423589)

  • 1. Lessons from Kawasaki disease: all brands of IVIG are not equal.
    Stiehm ER
    J Pediatr; 2006 Jan; 148(1):6-8. PubMed ID: 16423589
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
    Tsai MH; Huang YC; Yen MH; Li CC; Chiu CH; Lin PY; Lin TY; Chang LY
    J Pediatr; 2006 Jan; 148(1):38-43. PubMed ID: 16423595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S; Doré PC; Sewell WA
    Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistant Kawasaki disease.
    Nachiappan J; May M; Hawker RE; Hong P
    J Paediatr Child Health; 2004; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease in a US army soldier highlights surveillance.
    Chang C; Wood JC; Strickling WA; Walsh DS
    Int J Dermatol; 2006 Jan; 45(1):83-4. PubMed ID: 16426385
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kawasaki syndrome in adults: treatment with polyvalent intravenous immunoglobulins].
    Pavese P; Brion JP; Meusnier T; Stahl JP
    Ann Med Interne (Paris); 1997; 148(3):287-8. PubMed ID: 9255342
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoglobulin in suspected Kawasaki disease].
    García Soblechero E; Gómez Santos E; Domínguez Quintero ML; González Vila L
    An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Yang KD; Liang CD; Bong CN; Yu HR; Wang L; Wang CL
    Pediatr Allergy Immunol; 2007 Jun; 18(4):354-9. PubMed ID: 17584314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease.
    Seki M; Kobayashi T; Kobayashi T; Morikawa A; Otani T; Takeuchi K; Ayusawa M; Tsuchiya K; Yasuda K; Suzuki T; Shimoyama S; Ikeda K; Ishii Y; Arakawa H
    Pediatr Infect Dis J; 2011 Feb; 30(2):145-7. PubMed ID: 20802375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST
    J Pediatr; 2003 Jun; 142(6):601-3. PubMed ID: 12838185
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiology patient pages. Kawasaki disease.
    Baker AL; Newburger JW
    Circulation; 2008 Aug; 118(7):e110-2. PubMed ID: 18695195
    [No Abstract]   [Full Text] [Related]  

  • 16. IVIG, aspirin, and Kawasaki disease.
    Morgan GJ; MacLeod C; Jenkins J; Stewart C; Craig B
    J Pediatr; 2003 Aug; 143(2):280-1; author reply 281. PubMed ID: 12970651
    [No Abstract]   [Full Text] [Related]  

  • 17. Parotitis and kawasaki disease in a child with Noonan syndrome.
    Douvoyiannis M; Belamarich PF; Litman N
    Pediatr Infect Dis J; 2008 Jan; 27(1):89-90. PubMed ID: 18162955
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.
    Lee TJ; Kim KH; Chun JK; Kim DS
    Yonsei Med J; 2008 Oct; 49(5):714-8. PubMed ID: 18972590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J; Szymanowska Z; Mazurek A
    Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Kawasaki disease.
    Taddio A; Rosé CD
    N Engl J Med; 2007 Jun; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.